These tumors may arise de novo or develop from the sarcomatous transformation of a precursor IDH-wildtype glioblastoma; however, rare sarcomatous transformations of IDH-mutant gliomas have been reported [2]. This evidence concerns the gene IDH2 and central nervous system cancer.